|
|
TABLE OF CONTENTS |
|
|
March 2016 Volume 17 Number 3 | Advertisement |
Impact Factor 29.852 * | In this issue Research Highlights Foreword Focus on: Pluripotent stem cells Reviews Focus on: Pluripotent stem cells Perspectives
| |
|
|
Advertisement |
|
Molecular Biology of Hearing and Deafness (17-20 May 2016)
This year's meeting will highlight and discuss recent discoveries in the field: new genes involved in deafness and new pathways that underlie the development, function, repair and regeneration of the auditory system.
Deadlines: Bursary: 22 Mar/ Abstract: 5 Apr/ Registration: 19 Apr | | |
|
|
Advertisement |
|
nature.com webcasts Join us for our upcoming webcast with live Q&A: COMBATING ANTIBIOTIC RESISTANCE Presented by BioPharma Dealmakers Date: Wednesday, March 9, 2016 Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET REGISTER FOR FREE Sponsored by: Antabio, Cempra, Helperby, Motif Bio, Polyphor | | |
|
|
Advertisement |
|
The Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center, Nature, Nature Cell Biology and Nature Reviews Cancer present: CANCER AS AN EVOLVING AND SYSTEMIC DISEASE March 12-15, 2016 | New York, NY, USA REGISTER NOW! | | |
|
|
|
|
|
|
FOREWORD | Top |
Nuclear reprogramming and cell replacement therapies J. B. Gurdon Published online: 23 February 2016 p137 | doi:10.1038/nrm.2016.11 J. B. Gurdon introduces this Focus issue by discussing the importance of the discovery of induced pluripotent stem cells 10 years ago and current challenges for the development of cell replacement therapies. Abstract | Full Text | PDF
|
|
Focus on: Pluripotent stem cells | REVIEWS | Top | Molecular features of cellular reprogramming and development Zachary D. Smith, Camille Sindhu & Alexander Meissner Published online: 17 February 2016 p139 | doi:10.1038/nrm.2016.6
The ectopic expression of a defined set of transcription factors can experimentally reprogramme somatic cells into other cell types, including pluripotent cells. This method enables exploration of the molecular characteristics of pluripotency, cell specification, differentiation and cell fate stability, as well as their transcriptional and epigenetic regulation. Abstract | Full Text | PDF | Supplementary information
| Dynamic stem cell states: naive to primed pluripotency in rodents and humans Leehee Weinberger, Muneef Ayyash, Noa Novershtern & Jacob H. Hanna Published online: 10 February 2016 p155 | doi:10.1038/nrm.2015.28
Recent advances in our understating of the molecular underpinnings of alternative primed- and naive-like pluripotent states in rodents and humans highlight potential functional benefits of naive pluripotency and identify key unanswered questions in this rapidly evolving field. Abstract | Full Text | PDF | Supplementary information
| Pluripotent stem cells in disease modelling and drug discovery Yishai Avior, Ido Sagi & Nissim Benvenisty Published online: 28 January 2016 p170 | doi:10.1038/nrm.2015.27 The use of cultured human pluripotent stem cells (PSCs) to model human diseases has revolutionized the ways in which we study monogenic, multigenic and epigenetic disorders, by overcoming some of the limitations of animal models. PSC-based disease models are generated using various strategies and can be used for the discovery of new drugs and therapies. Abstract | Full Text | PDF
| PERSPECTIVES | Top | TIMELINE A decade of transcription factor-mediated reprogramming to pluripotency Kazutoshi Takahashi & Shinya Yamanaka Published online: 17 February 2016 p183 | doi:10.1038/nrm.2016.8 This year marks the tenth anniversary of the generation of induced pluripotent stem cells (iPSCs) by transcription factor-mediated somatic cell reprogramming. Takahashi and Yamanaka portray the path towards this ground-breaking discovery and discuss how, since then, research has focused on understanding the mechanisms underlying iPSC generation and on translating such advances to the clinic. Abstract | Full Text | PDF | Supplementary information
| SCIENCE AND SOCIETY Pluripotent stem cells progressing to the clinic Alan Trounson & Natalie D. DeWitt Published online: 23 February 2016 p194 | doi:10.1038/nrm.2016.10 Advances in the derivation of pluripotent stem cells (PSCs) and their differentiation to specific cell types could have diverse clinical applications. Trounson and DeWitt provide an overview of the progress in using embryonic stem cell and induced PSC derivatives for disease treatment and discuss the potential and limitations of such approaches. Abstract | Full Text | PDF
|
|
|
|
|
Advertisement |
|
|
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | |
No comments:
Post a Comment